SCHEMBL7033719

SCHEMBL7033719

N#CBr.O=C(n1ccnc1)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.37
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP24A1 Q07973 1/20 0.31
BTN3A1 O00481 1/20 0.30
CA12 O43570 1/20 0.30
GGPS1 O95749 1/20 0.30
CA2 P00918 1/20 0.30
LMNA P02545 1/20 0.30
MMP2 P08253 1/20 0.30
FDPS P14324 1/20 0.30
MMP9 P14780 1/20 0.30
MMP8 P22894 1/20 0.30
MMP14 P50281 1/20 0.30
CA9 Q16790 1/20 0.30
CA14 Q9ULX7 1/20 0.30
FAAH O00519 1/20 0.30
MGLL Q99685 1/20 0.30
EGLN3 Q9H6Z9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL156615 0.91 MAPT (0.37) CYP19A1MAPTL3MBTL1ALDH1A1CYP24A1
SCHEMBL13446154 0.79 L3MBTL1 (0.40) CYP19A1MAPTL3MBTL1ALDH1A1CYP24A1
SCHEMBL3027719 0.76 L3MBTL1 (0.38) CYP19A1MAPTL3MBTL1ALDH1A1CYP24A1
SCHEMBL9610803 0.76 CYP24A1 (0.38) MAPTL3MBTL1ALDH1A1CYP24A1LMNA
SCHEMBL20996818 0.76 MAPT (0.36) CYP19A1MAPTL3MBTL1ALDH1A1CYP24A1
SCHEMBL9109216 0.75 CYP19A1 (0.37) CYP19A1MAPTALDH1A1CYP24A1BTN3A1
SCHEMBL14219626 0.73 NFKB1 (0.39) MAPTALDH1A1CYP24A1LMNAEGLN3
SCHEMBL22160768 0.73 CYP24A1 (0.37) MAPTL3MBTL1ALDH1A1CYP24A1LMNA
SCHEMBL999664 0.73 L3MBTL1 (0.36) MAPTL3MBTL1ALDH1A1CYP24A1FAAH
SCHEMBL19239719 0.71 ALDH1A1 (0.34) CYP19A1MAPTL3MBTL1ALDH1A1CYP24A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030021798-A1 Use of mCRP to enhance immune responses IMMTECH INTERNATIONAL INC. 2003-01-30 US disclosed
US-6455046-B1 MODIFIED C-REACTIVE PROTEIN OR A MUTANT-MCRP, IMMUNOGEN, VACCINE IMMTECH INTERNATIONAL, INC. 2002-09-24 US disclosed
US-6280743-B1 VACCINE COMPRISING HAPTEN AND MODIFIED C-REACTIVE PROTEIN OR MUTANT THEREOF IN PHARMACEUTICALLY-ACCEPTABLE VEHICLE IMMTECH INTERNATIONAL, INC. 2001-08-28 US disclosed
US-6190670-B1 ELICITING AN IMMUNE RESPONSE TO A HAPTEN IN AN ANIMAL BY ADMINISTERING TO ANIMAL EFFECTIVE AMOUNT OF HAPTEN IN ASSOCIATION WITH AN EFFECTIVE AMOUNT OF MODIFIED C-REACTIVE PROTEIN (MCRP) OR A MUTANT-MCRP IMMTECH INTERNATIONAL INC. 2001-02-20 US disclosed
WO-2000061181-A1 USE OF mCRP TO ENHANCE IMMUNE RESPONSES IMMTECH INTERNATIONAL, INC. (US) 2000-10-19 WO disclosed
EP-0605627-B1 IMMUNOASSAY FOR IDENTIFYING ALCOHOLICS AND MONITORING ALCOHOL CONSUMPTION MAKHLOUF SAMAR (US) 1999-05-19 EP disclosed
WO-1999003490-A1 PROTEINS AND PEPTIDES FOR CONTRACEPTIVE VACCINES AND FERTILITY DIAGNOSIS NORTHWESTERN UNIVERSITY (US) 1999-01-28 WO disclosed
US-5702904-A Immunoassay for identifying alcoholics and monitoring alcohol consumption IMMTECH INTERNATIONAL, INC. (US) 1997-12-30 US disclosed
WO-1997026001-A1 PROTEINS AND PEPTIDES FOR CONTRACEPTIVE VACCINES AND FERTILITY DIAGNOSIS NORTHWESTERN UNIVERSITY (US) 1997-07-24 WO disclosed
EP-0487621-B1 IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS UNIV NORTHWESTERN (US) 1996-10-02 EP disclosed
US-5484735-A Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids NORTHWESTERN UNIVERSITY (US) 1996-01-16 US disclosed
EP-0487621-A4 IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS 1992-06-24 EP disclosed
EP-0487621-A1 IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS. UNIV NORTHWESTERN (US) 1992-06-03 EP disclosed
WO-1991002978-A1 IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS NORTHWESTERN UNIVERSITY (US) 1991-03-07 WO disclosed